KeyaMedical
  • Home
  • Products
    • DeepVessel FFR
    • CuraRad-ICH
  • Solutions
    • Diagnostic Solutions
    • Treatment Solutions
  • About Us
  • Resources
    • News
    • Publications
    • Glossary
  • Contact Us
    • DeepVessel FFR Demo
    • Solutions Inquiry
  • Careers
Select Page
DeepVessel 3D Visualization Processing Software Receives Regulatory Approval in China

DeepVessel 3D Visualization Processing Software Receives Regulatory Approval in China

by KeyaMedical | Apr 13, 2021 | All News, Press

Keya Medical has received regulatory approval in China for its DeepVessel 3D Visualization Processing Software. The AI-based software medical device is designed for visualization reading of multiphase CT images and 3D models.

Dr. Kunlin Cao Named to 2021 Forbes China Up-and-Coming Businesswomen List

Dr. Kunlin Cao Named to 2021 Forbes China Up-and-Coming Businesswomen List

by KeyaMedical | Feb 25, 2021 | All News, Press

Keya Medical’s President of R&D, Dr. Kunlin Cao, has been recognized on the 2021 Forbes China Up-and-Coming Businesswomen list. The list highlights 20 accomplished women who have each played a significant role in shaping China’s business landscape.

Keya Medical Raises $46M in Series D Round

Keya Medical Raises $46M in Series D Round

by KeyaMedical | Jan 14, 2021 | All News, Investors, Press

Keya Medical has raised $46 million in Series D funding. This funding round was led by new and existing investors, including CICC Capital, Shanghai Artificial Intelligence Investment Fund, Qianhai Gaozu Asset Management Fund, and IN CAPITAL.

Keya Medical Closes $30 Million Series C Funding Round Led by IDG Capital

Keya Medical Closes $30 Million Series C Funding Round Led by IDG Capital

by KeyaMedical | Nov 12, 2020 | All News, Investors, Press

Keya Medical announced that it has completed a $30 Million Series C Funding Round led by IDG Capital, with participation from investors Alwin Capital, Source Code Capital, and Tasly Group.

Keya Medical Awarded China Health Innovation Award at 2020 DEMO China

Keya Medical Awarded China Health Innovation Award at 2020 DEMO China

by KeyaMedical | Oct 19, 2020 | Press

On Oct. 17 and 18, the Chengdu Science and Technology Bureau hosted the 2020 DEMO China Innovation Finals, bringing together leading companies across the country.

Keya Medical Wins 2020 Ernst & Young Fudan China’s Most Promising Company Award

Keya Medical Wins 2020 Ernst & Young Fudan China’s Most Promising Company Award

by KeyaMedical | Sep 18, 2020 | Press

On Sept. 18, Keya Medical was recognized as the winner of China’s Most Promising Company award because of its leading R&D team and innovative cardiovascular product line.

« Older Entries

Categories:

Recent Posts

  • DeepVessel 3D Visualization Processing Software Receives Regulatory Approval in China
  • Deep Learning-based CT-FFR Reduces the Need for Invasive Coronary Angiography
  • Moving Toward a Coronary CTA-first Strategy: Current Evidence, Guidelines, & Recommendations
  • Dr. Kunlin Cao Named to 2021 Forbes China Up-and-Coming Businesswomen List
  • The Value of Deep Learning-based CT-FFR in Detecting Coronary Stenosis & Predicting Outcomes

Recent Comments

    Copyright Keya Medical © 2021